Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Novel melatonin compounds and preparation methods thereof and applications in medicine

A technology for melatonin and compounds, applied to novel melatonin compounds and their preparation and medical applications, can solve the problems of tolerance, unfavorable medication, and unsuitability for use by most patients, and achieves The effect of improving oral utilization and prolonging half-life

Inactive Publication Date: 2018-01-09
HC SYNTHETIC PHARMA CO LTD
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Tricyclic antidepressants, although effective in the treatment of moderate to severe depression, have widespread tolerability issues and are not suitable for most patients
As the world's first melatonin receptor MT1 and MT2 agonist antidepressant, agomelatine was found to cause adverse reactions such as skin allergies, oral ulcers, nausea, and stomach discomfort after oral administration at therapeutic doses. It is easy to cause rejection in patients, which is not conducive to medication

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel melatonin compounds and preparation methods thereof and applications in medicine
  • Novel melatonin compounds and preparation methods thereof and applications in medicine
  • Novel melatonin compounds and preparation methods thereof and applications in medicine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Embodiment 1: Preparation of N-((2-(3-methoxypropoxy)naphthalene-8-yl)ethyl)acetamide (compound I-1)

[0031]

[0032] Compound I-1

[0033] Take 10.0 g of (2-(3-methoxypropoxy)naphthalene-8-yl)methylamine and dissolve it in 100 ml of acetonitrile. Then 6.48 g of acetic anhydride was added. Heat to reflux for 6 hours. Add 1% activated carbon in total volume to the reaction liquid, reflux for decolorization for 15 min, and filter. The filtrate was concentrated to dryness under reduced pressure, and the residue was separated by HPLC to obtain 5.6 g of compound I-1.

Embodiment 2

[0034] Example 2: Preparation of N-((2-(3-(trifluoromethyl)propoxy)naphthalene-8-yl)ethyl)acetamide (Compound I-2)

[0035]

[0036] Compound I-2

[0037] Take 10.0 g of (2-(3-(trifluoromethyl)propoxy)naphthalene-8-yl)methylamine and dissolve it in 100 ml of acetonitrile. Then 6.48 g of acetic anhydride was added. Heat to reflux for 6 hours. Add 1% activated carbon in total volume to the reaction liquid, reflux for decolorization for 15 min, and filter. The filtrate was concentrated to dryness under reduced pressure, and the residue was separated by HPLC to obtain 5.0 g of compound I-2.

Embodiment 3

[0038] Embodiment 3: Preparation of (2-(3-methoxypropoxy)naphthalene-8-yl)-N,N-dimethylethylamine (compound 1-3)

[0039]

[0040] Compound I-3

[0041] Take 10.0 g of (2-(3-methoxypropoxy)naphthalene-8-yl)methanamine, add 100 ml of acetonitrile and stir to dissolve. Then 5.7 g of dimethyl sulfate was added. Heat to reflux for 6 hours. Add 1% activated carbon in total volume to the reaction liquid, reflux for decolorization for 15 min, and filter. The filtrate was concentrated to dryness under reduced pressure, and the residue was separated by HPLC to obtain 4.5 g of compound I-3.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to novel melatonin compounds and preparation methods thereof and applications in medicine, and concretely relates to the novel melatonin compounds represented by a general formula (I), the preparation methods thereof, drug compositions containing the compounds, and the applications of the compounds or the drug compositions which are used as therapeutic agents for preparing drugs which treat depression or periventricular leukomalacia, wherein a definition of each substituent in the general formula (I) is same to that of claims.

Description

technical field [0001] The invention relates to a melatonin compound and its non-toxic pharmaceutically acceptable salt, preparation method, pharmaceutical composition containing them and clinical application, especially for the treatment of depression. Background technique [0002] Disruption of the circadian rhythm pattern has been considered as one of the etiological factors in the pathophysiology of depression, and the disturbance of this internal rhythm is the characteristic of abnormal changes in mood, so the normalization of this type of rhythm impairment has been identified as an anti-inflammatory factor. A new measure of drug efficacy for depression. [0003] Melatonin is an endogenous neurohormone that is only secreted by the anterior pituitary gland of the pineal gland at night, and acts on melatonin receptors concentrated in the suprachiasmatic nucleus (SCN) of the hypothalamus to participate in mediation The mammalian circadian rhythm, the well-known guardian o...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07C233/18C07C217/58A61K31/165A61K31/137A61P25/24A61P25/00
Inventor 陆华龙
Owner HC SYNTHETIC PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com